1. Morgner A, Bayerdorffer E, Neubauer A, et al. Helicobacter
pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
Gut 2001; 48:290-2
2. Sackmann M, Morgner A, Rudolph B, et al. Regression of
gastric MALT lymphoma after eradication of Helicobacter pylori is predicted
by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology
1997;113:1087-90
3. Morgner A, Miehlke S, Fischbach W, et al. Complete Remission
of Primary High-Grade B-Cell Gastric Lymphoma After Cure of Helicobacter pylori
Infection. J Clin Oncol 2001;19:2041-
4. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al.
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter
pylori treatment. Gut 2001;48:297-303
5. Morgner A, Bayerdorffer E, Neubauer A, et al. Malignant
tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma
and Helicobacter pylori. Gastroenterol Clin North Am 2000;29:593-607
6. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment
of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled
trial. Ann Intern Med 1999;131:88-95.
7. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri
S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch
T, Molina T, Taal BG, Elena S, Thomas T, Zinzani
PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson
PG, Du MQ. T(11;18) is a marker for all stage gastric MALT lymphomas
that will not respond to H. pylori eradication. Gastroenterology. 2002
May;122(5):1286-94.
8. Fusaroli P, Buscarini E, Peyre S, Federici T, Parente
F, De Angelis C, Bonanno G, Meroni E, Napolitano V, Pisani
A, Sottili S, Togliani T, Caletti G. Interobserver agreement
in staging gastric malt lymphoma by EUS. Gastrointest Endosc. 2002 May;55(6):662-8.
Recent Review:
Stolte M, Bayerdörffer E, Morgner A, Alpen
B, Wündisch T, Thiede C, Neubauer A. Helicobacter and
gastric MALT lymphoma. Gut. 2002 May;50 Suppl 3:III19-24.
